One Medical (ONEM) priced at the low end of the range to raise $245 million at a $1.95 billion market cap. The company which owns and operates a 77 clinic network of membership-based primary-care clinics expanded its gross margin and accelerated growth in the 9mo19.
In the largest household goods IPO ever, Reynolds (REYN) priced within the range at $26 to raise $1.2 billion at a market cap of $5.3 billion. The company has cut $126 million in costs in the past two years and 65% of 2018 sales were from products with #1 market share. Reynolds finished up 9.8%.
Oncology biotech Black Diamond Therapeutics (BDTX) priced above the range to raise $201 million at a market cap of $672 million. The Phase 1-ready biotech boasted a first day pop of 108% despite its very early stage and limited portfolio, and finished up 107.8%.
Late-stage dermatology biotech Arcutis Biotherapeutics (ARQT) priced its upsized deal at the high end of the range, raising $159 million ($50 million from existing shareholders) at a market cap of $657 million. The company’s leading candidate is currently in two pivotal Phase 3 trials for psoriasis, with topline results expected in 1H21. Arcutis finished up 28.2%
Chinese cancer screening provider AnPac Bio-Medical Science (ANPC) priced its downsized IPO at the low end of the range to raise $16 million at a market cap of $134 million. The challenging environment for Chinese issuers has carried into 2020, and AnPac finished down 15.7%.
| 5 IPOs During the Week of January 27th, 2020 | |||||
|---|---|---|---|---|---|
| Issuer Business |
Deal Size |
Market Cap at IPO |
Price vs. Midpoint |
First Day Return |
Return at 01/31 |
| Black Diamond Tx (BDTX) | $201M | $672M | 12% | +108% | +97% |
| Phase 1-ready biotech developing targeted kinase inhibitors for solid tumors. | |||||
| One Medical (ONEM) | $245M | $1,952M | -7% | +58% | +58% |
| Operates 77 membership-based health clinics under the One Medical brand. | |||||
| Arcutis Biotherapeutics (ARQT) | $159M | $657M | 6% | +28% | +28% |
| Phase 3 biotech developing topical therapies for common skin diseases. | |||||
| Reynolds Consumer (REYN) | $1,226M | $5,272M | -2% | +10% | +10% |
| Leading provider of household and kitchen products. | |||||
| AnPac Bio-Medical Science (ANPC) | $16M | $134M | -8% | -6% | -16% |
| Chinese provider of multi-cancer screening tests. | |||||
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.